drugset
drugset / Trial / NCT02272764

A Drug-Drug Interaction Study of ALKS 5461 in Healthy Volunteers

NCT02272764 ↗

Phase 1 Completed 24 enrolled Alkermes, Inc.
RandomizedCrossoverQuadruple-blindTreatment

Summary

This study will evaluate the impact of Itraconazole on the pharmacokinetics of ALKS 5461.

Timeline

Start
2014-10
Primary completion
2014-11
Completion
2014-11

Drugs

EvaluationDrugModalityDoseRoute
Subject ALKS 5461 Unknown — Other
Subject Itraconazole Small molecule — Oral

Indications

No indication recorded.